Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1974 Jun;49(6):463–466. doi: 10.1136/adc.49.6.463

Intracellular bactericidal effects of rifampicin in both normal and chronic granulomatous disease polymorphs

G Ezer, J F Soothill
PMCID: PMC1648774  PMID: 4852534

Abstract

Chronic granulomatous disease (CGD) polymorphs incubated with rifampicin before or after staphylococcal phagocytosis inactivated the bacteria. Lysates of normal polymorphs incubated with rifampicin inactivated bacteria. These effects were not due to damage to the polymorphs.

Polymorph lysates of rifampicin-treated CGD patients and healthy subjects inactivated bacteria, but the polymorphs of rifampicin-treated CGD patients did not kill the bacteria in vitro.

The role of rifampicin in the treatment of CGD patients and of other patients with intracellular infections is discussed.

Full text

PDF
463

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander J. W., Good R. A. Effect of antibiotics on the bactericidal activity of human leukocytes. J Lab Clin Med. 1968 Jun;71(6):971–983. [PubMed] [Google Scholar]
  2. BERENDES H., BRIDGES R. A., GOOD R. A. A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med. 1957 May;40(5):309–312. [PubMed] [Google Scholar]
  3. Baehner R. L., Nathan D. G. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med. 1968 May 2;278(18):971–976. doi: 10.1056/NEJM196805022781801. [DOI] [PubMed] [Google Scholar]
  4. Copeland J. L., Karrh L. R., McCoy J., Guckian J. C. Bactericidal activity of polymorphonuclear leukocytes from patients with severe bacterial infections. Tex Rep Biol Med. 1971 Winter;29(4):555–562. [PubMed] [Google Scholar]
  5. Deal W. B., Sanders E. Efficacy of rifampin in treatment of meningococcal carriers. N Engl J Med. 1969 Sep 18;281(12):641–645. doi: 10.1056/NEJM196909182811203. [DOI] [PubMed] [Google Scholar]
  6. Hoeprich P. D., Martin C. H. Effect of tetracycline, polymyxin B, and rifampin on phagocytosis. Clin Pharmacol Ther. 1970 May-Jun;11(3):418–422. doi: 10.1002/cpt1970113418. [DOI] [PubMed] [Google Scholar]
  7. Holmes B., Quie P. G., Windhorst D. B., Pollara B., Good R. A. Protection of phagocytized bacteria from the killing action of antibiotics. Nature. 1966 Jun 11;210(5041):1131–1132. doi: 10.1038/2101131a0. [DOI] [PubMed] [Google Scholar]
  8. Jones D. M., Tobin B. M., Butterworth A. Three cases of meningococcal infection in a family, associated with a deficient immune response. Arch Dis Child. 1973 Sep;48(9):742–743. doi: 10.1136/adc.48.9.742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kaplan E. L., Laxdal T., Quie P. G. Studies of polymorphonuclear leukocytes from patients with chronic granulomatous disease of childhood: bactericidal capacity for streptococci. Pediatrics. 1968 Mar;41(3):591–599. [PubMed] [Google Scholar]
  10. LANDING B. H., SHIRKEY H. S. A syndrome of recurrent infection and infiltration of viscera by pigmented lipid histiocytes. Pediatrics. 1957 Sep;20(3):431–438. [PubMed] [Google Scholar]
  11. Mandell G. L. Interaction of intraleukocytic bacteria and antibiotics. J Clin Invest. 1973 Jul;52(7):1673–1679. doi: 10.1172/JCI107348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mandell G. L., Vest T. K. Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies. J Infect Dis. 1972 May;125(5):486–490. doi: 10.1093/infdis/125.5.486. [DOI] [PubMed] [Google Scholar]
  13. McCabe W. R., Lorian V. Comparison of the antibacterial activity of rifampicin and other antibiotics. Am J Med Sci. 1968 Oct;256(4):255–265. doi: 10.1097/00000441-196810000-00007. [DOI] [PubMed] [Google Scholar]
  14. McCrae W. M., Raeburn J. A. Chronic granulomatosus disease: an attempt to stimulate phagocytic activity. Lancet. 1972 Jun 24;1(7765):1370–1371. doi: 10.1016/s0140-6736(72)91098-7. [DOI] [PubMed] [Google Scholar]
  15. Quie P. G., White J. G., Holmes B., Good R. A. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest. 1967 Apr;46(4):668–679. doi: 10.1172/JCI105568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Thompson E. N., Soothill J. F. Chronic granulomatous disease: quantitative clinicopathological relationships. Arch Dis Child. 1970 Feb;45(239):24–32. doi: 10.1136/adc.45.239.24. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES